voice search
Lgd-4033

Lgd-4033

Price:

Get Latest Price

In Stock

In Stock

Product Specifications

AppearanceWhite powder
CAS No.1165910-22-4
FeaturesHigh purity, Oral SARM, Selective, Non-steroidal, Research use
Molecular Weight338.25
Packaging1g; 10g; 100g; 500g; 1kg
Purity>99%
SolubilityDMSO
UsageResearch and development purposes only. Not for human or animal consumption.

Product Overview

Key Features

We are instrumental in providing to our valuable customers excellent quality LGD-4033 which is available with following specification:-
CAS No.: 1165910-22-4
Purity: >99%
Other Name: 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile
Appearance: white powder
Port: SH
Transport Information: BY AIR
Package: 1g;10g;100g;500g;1kg
Storage: At room temperature
Molecular weight:338.25
Application: LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to A
Delivery Time: ON REQUEST
Production Capacity: 1 Kilogram per Month
Solubility: DMSO

Clients can avail this LGD-4033 at industry leading prices from us.

Company Details

Established in 2008, WUHAN HENGHEDA PHARM COMPANY has made a name for itself in the list of top suppliers of Pharmaceutical Chemicals in India. The supplier company is located in Wuhan, Hubei, and is one of the leading sellers of listed products.
WUHAN HENGHEDA PHARM COMPANY is listed in Trade India's list of verified sellers offering supreme quality of (Mk-2866), 5,6-Diethyl-2,3-dihydro 1H-inden-2-amine Hydrochloride, 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone, etc. Buy Pharmaceutical Chemicals in bulk from us for the best quality products and service.

Business Type

Exporter, Manufacturer, Distributor, Supplier, Trading Company

Employee Count

30

Establishment

2008

Working Days

To

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

Wuhan, Hubei

Sales Manager

Ms. Cathy Peng

Address

Wuhan Private Science and Technology Park, Wuhan, Hubei, 430000, China

pharmaceutical intermediates in Wuhan

Report incorrect details

Compare With Similar Products